Study of bb2121 in Multiple Myeloma

NCT02658929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: bb2121

Sponsor

Celgene

Collaborators

[object Object]